0 Commentarii
0 Distribuiri
60 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Radiopharmaceutical Theranostics Market: Is 2026 the Year "Search and Destroy" Medicine Becomes the Standard of Care?As of January 23, 2026, the radiopharmaceutical theranostics market is identifying as the "fifth pillar" of cancer treatment, with its 2026 valuation projected to reach approximately $3.27 billion to $6.18 billion globally. The 2026 landscape is defined by a massive CAGR of up to 27.9%, driven by the clinical success of "Radioligand Therapies" that combine diagnostic imaging and therapeutic...0 Commentarii 0 Distribuiri 475 Views 0 previzualizare
-
The Integration of Artificial Intelligence and Personalized Dosimetry in the Radiopharmaceutical MarketIn the realm of nuclear medicine, delivering a lethal dose of radiation to a tumor while sparing healthy organs is a delicate balancing act. Historically, radioligand therapies have been administered using a standardized, "one-size-fits-all" dosing approach based on a patient's body weight or surface area. However, as the Radiopharmaceutical Market matures, the industry is rapidly pivoting...0 Commentarii 0 Distribuiri 104 Views 0 previzualizare